MITO
Stealth BioTherapeutics Corp. ADS
MITO
MITO
Delisted
MITO was delisted on the 15th of November, 2022.
13 hedge funds and large institutions have $3.62M invested in Stealth BioTherapeutics Corp. ADS in 2021 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 0 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
13
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.18M | |
| 2 | +$492K | |
| 3 | +$473K | |
| 4 |
BFM
Boothbay Fund Management
New York
|
+$147K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$124K |
Top Sellers
| 1 | -$75K | |
| 2 | -$67K | |
| 3 | -$41K | |
| 4 |
Goldman Sachs
New York
|
-$22K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$22K |